Molecular and cellular biomarkers for angiogenesis in clinical oncology
Authors:
- Francesco BertoliniFrancesco Bertolini
- Patrizia MancusoPMPatrizia Mancuso
- Yuval ShakedYSYuval Shaked
- Robert S. KerbelRKRobert S. Kerbel
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 12 (19-20) , 806-812
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationGenes & Development, 2007
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principalsBlood, 2006
- Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculatureBlood, 2006
- Vascular endothelial growth factor biology: clinical implications for ocular treatmentsBritish Journal of Ophthalmology, 2006
- Accrual Delayed in Adjuvant Bevacizumab TrialJNCI: Journal of the National Cancer Institute, 2006
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004
- Molecular regulation of vessel maturationNature Medicine, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000